WALTHAM, Mass.–(BUSINESS WIRE)–Nov 21, 2022–
Wolters Kluwer Health and NEJM Group have entered into an exclusive partnership to ensure that more researchers and clinicians around the world have access to the NEJM Group’s growing family of journals. Building on years of collaboration, this expanded partnership positions NEJM Group journals for sustainable global growth through Wolters Kluwer’s Ovid ® medical research platform. The publications that are currently part of it are the New England Journal of Medicine, NEJM Evidence, NEJM Catalyst Innovations in Care Delivery, NEJM Journal Watch, the NEJM archives and future journals of the NEJM group.
kAms:E A6CD36C:49E 36G2E >F=E:>65:2]q6<:;< 9:6C 96E G@==65:86 A6CD36C:49Ei k2 9C67lQ9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_aa“`f__dgc`^?=^Q C6=lQ?@7@==@HQm9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9 @>6^a_aa“`f__dgc`^?=^k^2mk^Am
kAm(@=E6CD z=FH6C w62=E9 H:== D6CG6 2D E96 6I4=FD:G6 5:8:E2= 5:DEC:3FE@C @7 DF3D4C:AE:@?DE@ E96 }6H t ?8=2?5 y@FC?2= @7 |65:4:?6[ }ty| tG:56?46[ }ty| r2E2=JDE 2?5 }ty| y@FC?2= (2E49 WvC2A9:4i qFD:?6DD (:C6Xk^Am
kAmk6>m~?86ëG6?22C56 5:DEC:3FE:6 4CF4:22= G@@C H6C6=5H:;5 36C6:
kAmQs6 >:DD:6 G2? 56 }ty| vC@FA 😀 96E 36G@C56C6? G2? >65:D496 <6??:D G2? @?56CK@6< ?22C A2E:ë?E6?K@C8[ H22C3:; 56 G6C32?56? H@C56? 86=685 EFDD6? @?EH:<<6=:?86? :? 56 <=:?:D496 H6E6?D492A 6? 56 <=:?:D496 AC2AD@?[ ‘:46 !C6D:56?E G2? }ty| vC@FA] Qs6 H6C6=5H:;56 G6C<@@A\ 6? >2C<6E:?822?H6K:896:5 G2? (@=E6CD z=FH6C K@C8E G@@C 6IEC2 <2?D6? @> 96E 36C6:
kAms@@C 56 D2>6?H6C<:?8 96336? :?DE:EFE:@?6=6 @?=:?6 23@??66D @A E:;5D49C:7E6? G2? 56 }ty| vC@FA E@682?8 E@E 9F? 23@??66\:?9@F5 K@H6= G:2 56 D:E6D G2? 56 }ty| vC@FA 2=D G:2 96E >65:D496@?56CK@6
kAmQw6E k6>m}6H t?8=2?5 y@FC?2= @7 |65:4:?6k^6>m 😀 66 ? G2? 56 >66DE 86C6DA64E66C56 6? :?G=@65C:;<6 >65:D496E:;5D49C:7E6? E6C H6C6=5[ AFE F:E 66? C:;<6 86D49:656?:D 6? H@C5E >66C 864:E66C5 52? 6?:8 2?56C E:;5D49C:7E[Q G6C<=22C56 ':
kAmw6E A2CE?6CD492A 3@FHE G@@CE @A 66? DE6C<6 32D:D 5:6:D G6CDE6C
kAm!F3=:42E:6D G2? 56 }ty| vC@FA 5:6 G:2 (@=E6CD z=FH6C @?56C :?DE6==:?86? KF==6? H@C56? G6CDAC6:5[ K:;? @?56C 2?56C6ik^Am
kF=mk=:mk6>mw6E k6>m}6H t?8=2?5 y@FC?2= @7 |65:4:?6k^6>mk^6>m[ 6C<6?5 2=D VD H6C6=5D E@@?22?86G6?56 >65:D496 E:;5D49C:7E[ =6G6CE 9@@8DE22?5[ 4@==68:22= 86E@6EDE @?56CK@6< 6? :?E6C24E:6G6 <=:?:D496 :?9@F5 22? 2CED6?[ 5@46?E6?[ @?56CK@6<6CD 6? 56 H6C6=5H:;56 >65:D496 86>66?D492A]k^=:mk=:mk6>mk6>m}ty| tG:56?46k^6>mk^6>m[ 52E G6C?:6FH6?5 @C:8:?66= @?56CK@6< 6? 7C:DD6[ 865FC756 :566ë? AC6D6?E66CE 3:; 96E @?EH6CA G2? <=:?:D496 AC@6G6? 6? <=:?:D496 36D=F:EG@C>:?8]k^=:mk=:mk6>mk6>m}ty| r2E2=VA x??@G2E:@?D:? r2C6 s6=:G6CJk^6>mk^6>m[ 66? A66C\C6G:6H65 E:;5D49C:7E 52E K:49 C:49E @A 56 ?:6FHDE6 :??@G2E:6D[ 8C@E6 :566ë? 6? AC2
kAmp=D 86G@=8 G2 ? 56K6 5:DEC:3FE:6@G6C66?<@>OF K2= (@=E6CD z=FH6C w62=E9 {62C?:?8[ #6D62C49 U2>Aj !C24E:46 56 5:8:E2=6 23@??6>6?ED@A3C6?8DE6? 6? 86C6=2E66C56 <@DE6? G2? 56 }ty| vC@FA G@@C 922C C6<6?:?8 ?6>6?] s6 @G6C66?<@>DE 9667E 66?A@D:E:6G6[ >22C :>>2E6C:ë=6 :>A24E @A 56 864@?D@=:566C56 C6DF=E2E6? G2? 56 (@=E6CD z=FH6C\8C@6A]k^am
kAmk6>m~G6C (@=E6CD z=FH6Ck^6>mk^Am
kAm(@=E6CD z=FH6C W(z{X 😀 66? H6C6=5=6:56C @A 96E 863:65 G2? AC@76DD:@?6=6 :?7@C>2E:6[ D@7EH2C6@A=@DD:?86? 6? 5:6?DE6? G@@C 4=:?:4:[ G6CA=668
kAm(@=E6CD z=FH6C C2AA@CE66C56 G@@C a_a` 66? ;22C@>K6E G2? € c[g >:=;2C5] s6 8C@6A 365:6?E <=2?E6? :? >66C 52? `g_=2?56?[ 9667E G6DE:8:?86? 😕 >66C 52? c_ =2?56? 6? 9667E H6C6=5H:;5 @?86G66C a_]___ >6?D6? 😕 5:6?DE]w6E 365C:;7:D 86G6DE:85:? p=A96? 22? 56? #: ; ?[ }656C=2?5]k^am
kAm(@=E6CD z=FH6C w62=E9 3:65E G6CEC@FH56 <=:?:D496 E649?@=@8:6 6? @A 36H:;D>2E6C:22= 8632D66C56 @A=@DD:?86? 5:6 4=:?:4:[ A2E:ë?E6?[ @?56CK@6<6CD 6? DEF56?E6? 36EC6<<6? 3:; 67764E:6G6 36D=F:EG@C>:?8 6? C6DF=E2E6? 😕 56 86K@?596:5DK@C8] (6 @?56CDE6F?6? <=:?:D496 67764E:G:E6:E[ =6C6? 6? @?56CK@6<[ <=:?:D49 E@6K:49E 6? ?2=6G:?8[ 6G6?2=D 52E2\@A=@DD:?86?] v2 G@@C >66C :?7@C>2E:6 @G6C @?K6 @A=@DD:?86? ?22C k2 9C67lQ9EEADi^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?
kAmv2 G@@C >66C:?7@C>2E:6?22C k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?
kAms6K6 36<6?5>2<:?8 :D @77:4:66= 86=56?5 :? 56 @C:8:?6=6 3C@?E22=] '6CE2=:?86? K:;? D=649ED 2=D =66D9F=A 365@6=5 6? >@6E6? H@C56? G6C86=6<6? >6E 56 E6[ 5:6 2=D 6?:86 C649ED86=5:8 :D]k^am
kAmq6<:;< 96E @@CDAC@?<6=:;<6 36C:49E @A k2 9C67lQ9EEAi^^3FD:?6DDH:C6]4@>Qm3FD:?6DDH:C6]4@>k^2mik2 9C67lQ9EEAADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_aa“`f__dgc`^?=^Q C6= lQ?@7@==@HQm9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_aa“`f__dgc`^?=^k^2mk^Am
kAmr~}%pr%i |65:2k^Am
kAmy@D9 s6$E672?@k^Am
kAm!F3=:4 #6=2E:@?D U2>Aj !F3=:4 p772:CD |2?286Ck^Am
kAm (@=E6CD z=FH6Ck^Am
kAmZ` Wfg`X hgb\dehfk^Am
kAmk2 9C67lQ>2:=E@i;@D9F2]56DE672?@oH@=E6CD<=FH6C]4@>Qm;@D9F2]56DE672?@oH@=E6CD<=FH6C]4@>k^2mk^am
kAmzt*(~#si |p$$prw&$t%%$ t&#~!t &}x%ts $%p%t$ }~#%wp|t#xrp p$xp !prxuxrk^Am
kAmx}s&$%#* zt*(~#si qx~%trw}~{~v* wtp{%w %#px}x}v !wp#|prt&%xrp{ r~}%x}&x} v!&q{x$wx}v!#pr%xrt |p}pvt|t}% |p}pvts rp#t ts&rp%x~} vt}t#p{ wtp{%ww~$!x%p {$ r~||&}xrp%x~}$ r{x}xrp{ %#xp{$ rp#sx~{~v*k^Am
kAm$~&#rti (@=E6CD z=FH6C w62=E9k^Am
kAmr@AJC:89E qFD:?6DD (:C6 a_aa]k^Am
kAm!&qi “^a`^a_aa _aib_ p|^sx$ri “^a`^a_aa _aiba p|k^Am
kAmk2 9C67lQ9EEAi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_aa“`f__dgc`^?=Qm9EEAi^^HHH]3FD:?6DDH:C6]4@>^ ?6HD^9@>6^a_aa“`f__dgc`^?=k^2mk^Am
Copyright BusinessWire 2022.
#England #Journal #Medicine #NEJM #Group #Collaborate #Wolters #Kluwer #Expand #Global #Reach #Leading #Journals